Translational Research Solutions
Comprehensive analyses of DNA, RNA, and epigenomes by using next-generation sequencing (NGS), microarray, and other technologies are used for such tasks as biomarker discovery, research into mechanisms of action, and new target discovery.
Comprehensive analyses of proteins by using mass spectrometry, chemical biology, and other cutting-edge technologies are used for such tasks as research into mechanisms of action, new target discovery, and biomarker discovery.
Analyses of “Omics” data and analytical platform development by using machine learning (including artificial intelligence) are used for such tasks as biomarker discovery, research into mechanisms of action, and new target discovery.
Microfluidic PCR technology, digital barcode technology, and in situ hybridization are used to analyze gene expression and mutations.
Western blot and flow cytometry are used to analyze biomarkers. Multiplex technologies for cytokine measurement, blood biochemistry, and kinase panel profiling are used to evaluate the efficacy and mechanism of action of candidate drugs.
Technologies for pathological specimen preparation, laser microdissection, immunohistochemical staining, FISH, and electron microscopy are used for pathological evaluation, biomarker analysis, and target cancer identification.
Cell line panels
Cancer cell-line panels with various Omics data are used for biomarker discovery, mechanism of action analysis, target cancer identification, and establishment of drug-resistant cell lines.